1,012
Participants
Start Date
February 29, 2008
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
Varicella (chickenpox) lesion sampling
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Taufkirchen
GSK Investigational Site, Deisenhofen
GSK Investigational Site, Olching
GSK Investigational Site, Gilching
GSK Investigational Site, Fürstenfeldbruck
GSK Investigational Site, Grafrath
GSK Investigational Site, Weilheim
GSK Investigational Site, Freising
GSK Investigational Site, Kirchheim
GSK Investigational Site, Grafing
GSK Investigational Site, Baldham
Lead Sponsor
Ludwig-Maximilians - University of Munich
OTHER
GlaxoSmithKline
INDUSTRY